O Negative Blood Type and Dementia Risk: Current Evidence and Context

Some observational studies report a modestly lower risk of Alzheimer's disease in blood group O individuals (including O negative), but findings are inconsistent and mechanisms unclear.

Evidence Summary

• ABO and cognition: Meta-analyses show weak associations; group O may have slightly lower AD risk vs. non-O, but effect sizes are small (OR ~0.8–0.9).
• Mechanistic hypotheses: ABO antigens influence von Willebrand factor, coagulation, inflammation, and possibly amyloid clearance—but direct causal links to neurodegeneration are unproven.
• Confounding: Population stratification, cardiovascular comorbidities, and lifestyle factors may explain associations.

Key Perspective

Blood type is a non-modifiable, minor risk factor. Dementia risk is predominantly driven by:

• Age (strongest)
• Genetics (APOE ε4, others)
• Cardiovascular health (hypertension, diabetes, lipids)
• Lifestyle (diet, exercise, cognitive engagement, sleep)
• Education and socioeconomic factors

No blood group confers immunity. Focus prevention efforts on modifiable risks regardless of blood type.